John Drakenberg

Co-founder & CEO, Alex Therapeutics

John Drakenberg is the Co-founder and CEO of Alex Therapeutics. Alex Therapeutics is a digital therapeutics (DTx) company that partners with pharmaceutical companies to create and license digital therapies. With the proven “Alex DTx Platform”, expertise in patient-centric design, and evidence-based psychology, Alex Therapeutics is uniquely positioned to deliver safe and effective DTx Software-as-a-medical-devices (SaMDs) to the global market. The company has treated tens of thousands of patients, has clinically validated products, as well as overwhelmingly positive patient and partner testimonials.

Leonardo Royal Hotel London Tower Bridge

17 November 2022